UBS Call 300 DHR 20.12.2024/ DE000UM7Z953 /
2024-11-08 8:03:29 PM | Chg.+0.001 | Bid8:03:29 PM | Ask8:03:29 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.007EUR | +16.67% | 0.007 Bid Size: 7,500 |
0.160 Ask Size: 7,500 |
Danaher Corporation | 300.00 USD | 2024-12-20 | Call |
GlobeNewswire
08-20
Intelligent Product Solutions Announces that Brad Carlson Joins as VP of Technology and Business Dev...
GlobeNewswire
03-08
Resilinc CEO Honored With a 2024 Pros to Know Lifetime Achievement Award from Supply & Demand Chain ...
GlobeNewswire
02-26
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Te...
GlobeNewswire
01-29
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Te...
GlobeNewswire
2023-12-13
Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
GlobeNewswire
2023-11-15
Brady Corporation elects Board of Directors and declares regular dividend to shareholders
GlobeNewswire
2023-11-14
Lincoln Electric Appoints J. Ashley Hall as Senior Vice President, Global Procurement
GlobeNewswire
2023-11-01
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign
GlobeNewswire
2023-10-16
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher...
GlobeNewswire
2023-10-12
Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicate...
GlobeNewswire
2023-10-08
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RPT, HT, ABCM, AGE
GlobeNewswire
2023-10-02
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer